NO20063483L - Therapeutic combinations - Google Patents

Therapeutic combinations

Info

Publication number
NO20063483L
NO20063483L NO20063483A NO20063483A NO20063483L NO 20063483 L NO20063483 L NO 20063483L NO 20063483 A NO20063483 A NO 20063483A NO 20063483 A NO20063483 A NO 20063483A NO 20063483 L NO20063483 L NO 20063483L
Authority
NO
Norway
Prior art keywords
mammal
therapeutic combinations
inhibitors
administering
treating
Prior art date
Application number
NO20063483A
Other languages
English (en)
Inventor
Amy Karen Patick
Jennifer Lou Hammond
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20063483L publication Critical patent/NO20063483L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives fremgangsmåter for å behandle en HIV-infeksjon i et pattedyr ved administrering til pattedyret av en terapeutisk effektiv mengde av en kombinasjon av forbindelser. Foreliggende oppfinnelse vedrører også materialer omfattende visse forbindelser som er nyttige som inhibitorer av HIV-protease-enzymet og minst ett ytterligere terapeutisk middel.
NO20063483A 2004-01-30 2006-07-31 Therapeutic combinations NO20063483L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54074904P 2004-01-30 2004-01-30
US61500004P 2004-10-01 2004-10-01
PCT/IB2005/000101 WO2005082362A1 (en) 2004-01-30 2005-01-17 Therapeutic combinations

Publications (1)

Publication Number Publication Date
NO20063483L true NO20063483L (no) 2006-08-30

Family

ID=34915540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063483A NO20063483L (no) 2004-01-30 2006-07-31 Therapeutic combinations

Country Status (12)

Country Link
US (1) US20050171038A1 (no)
EP (1) EP1713470A1 (no)
JP (1) JP2007519704A (no)
KR (1) KR20060114374A (no)
AU (1) AU2005216710A1 (no)
BR (1) BRPI0506493A (no)
CA (1) CA2555171A1 (no)
IL (1) IL177155A0 (no)
MX (1) MXPA06008632A (no)
NO (1) NO20063483L (no)
RU (1) RU2006128606A (no)
WO (1) WO2005082362A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060084628A1 (en) * 2004-10-19 2006-04-20 Achillion Pharmaceuticals Combination therapy for treating viral infections
WO2006104646A1 (en) * 2005-03-11 2006-10-05 Smithkline Beecham Corporation Hiv protease inhibitors
WO2007033208A2 (en) * 2005-09-12 2007-03-22 University Of Maryland Biotechnology Institute Off. Of Research Admin/Tech. Dev. Use of indirubin and its derivatives in the treatments of hiv infection and heart failure
FR2892719B3 (fr) * 2005-11-02 2008-01-18 Sep Innovaterm Barriere physico-chimique anti-termites constituee par du beton dans lequel a ete incorpore dans toute la masse un insecticide contre les termites
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
ES2395101T3 (es) * 2006-03-02 2013-02-08 Siga Technologies, Inc. Medicamentos antivirales para tratamiento de infecciones por arenavirus
NZ573888A (en) * 2006-07-21 2012-02-24 Gilead Sciences Inc Aza-peptide protease inhibitors
WO2008078200A2 (en) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Protease inhibitors
US20140315936A1 (en) * 2011-11-18 2014-10-23 Avexa Limited Apricitabine and pi combination therapy
CN105669749B (zh) * 2014-08-14 2018-03-30 赫斯（西安）生物科技有限公司 抗病毒药物及组合物
EP3645029B1 (en) * 2017-06-26 2023-01-18 Institut Pasteur Treatments to eliminate hiv reservoirs and reduce viral load

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2002000136A (es) * 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis

Also Published As

Publication number Publication date
AU2005216710A1 (en) 2005-09-09
US20050171038A1 (en) 2005-08-04
BRPI0506493A (pt) 2007-02-13
WO2005082362A1 (en) 2005-09-09
KR20060114374A (ko) 2006-11-06
CA2555171A1 (en) 2005-09-09
EP1713470A1 (en) 2006-10-25
IL177155A0 (en) 2008-04-13
JP2007519704A (ja) 2007-07-19
MXPA06008632A (es) 2006-09-04
RU2006128606A (ru) 2008-03-10

Similar Documents

Publication Publication Date Title
NO20063483L (no) Therapeutic combinations
EA200870380A1 (ru) Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета
NO20083216L (no) Myke proteaseinhibitorer og pro-myke former derav
BR0315796A (pt) Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero
EA200801538A1 (ru) Лечение диабета 2 типа комбинацией ингибитора дипептидилпептидазы iv (dpiv) и метформина или тиазолидиндиона
NO20052380L (no) Beta-amino-heterosykliske dipeptidylpeptidaseinhibitorer for behandling og forhindring av diabetes
NO20065864L (no) Femleddete heterosykler anvendelige som serinproteaseinhibitorer
CR8603A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
EA201001523A1 (ru) Ингибиторы матриксной металлопротеазы на основе арилсульфонамида
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
ATE318139T1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
NO20080150L (no) Inhibitorer av AKT-aktivitet
EA200800670A1 (ru) Ингибиторы сериновых протеаз
BR0009167A (pt) Inibidores de enzima impdh
NO20080785L (no) Behandling av kreft
EA200701467A1 (ru) Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
NO20075973L (no) Dipeptidyl-peptidase-IV-inhibitorer
EP1406872A4 (en) DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20045429L (no) Kombinasjon av organiske forbindelser
MX2009009176A (es) Inhibidores de serina-proteasas.
NO20083885L (no) Fremgangsmate for behandling av inflammatoriske sykdommer
NO20083032L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av mani og bipolar forstyrrelse
NO20091353L (no) Serine hydrolaseinhibitorer
WO2007117482A3 (en) Renin inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application